Anti-HFRSV monoclonal antibody (Wuhan Institute of Biological Products)

抗肾综合征出血热病毒单抗（武汉生物制品研究所）

Report date: 2025/06/30 11:36:10

Base Information

Drug NameAnti-HFRSV monoclonal antibody (Wuhan Institute of Biological Products)
Drug Alias Name注射用抗肾综合征出血热病毒单克隆抗体
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-GP
TargetsEnvelopment polyprotein
Therapy Area/IndicationsHemorrhagic Fevers, Viral
Global Approved IndicationsHemorrhagic Fevers, Viral
Approved Indications in ChinaHemorrhagic Fevers, Viral
Original Approved Country/TerritoryMainland China
Original Approved Date2015/01/07
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFourth Military Medical University Of Chinese People'S Liberation ArmyWuhan Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co LtdFourth Military Medical University Of Chinese People'S Liberation Army
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fevers, Viral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A